Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.50B | 6.50B | 5.06B | 5.54B | 6.52B | 6.33B |
Gross Profit | 2.39B | 2.39B | 1.84B | 2.14B | 3.31B | 3.26B |
EBITDA | -511.07M | -510.18M | -811.37M | -275.96M | 1.47B | 2.07B |
Net Income | -546.29M | -546.29M | -830.75M | -320.78M | 964.09M | 1.40B |
Balance Sheet | ||||||
Total Assets | 6.28B | 6.28B | 6.53B | 7.24B | 7.76B | 3.52B |
Cash, Cash Equivalents and Short-Term Investments | 3.36B | 3.36B | 5.09B | 6.10B | 6.90B | 2.58B |
Total Debt | 86.66M | 86.66M | 0.00 | 0.00 | 3.00M | 9.00M |
Total Liabilities | 1.03B | 1.03B | 762.41M | 646.04M | 841.51M | 1.38B |
Stockholders Equity | 5.25B | 5.25B | 5.77B | 6.60B | 6.92B | 2.14B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -427.35M | -550.25M | -725.48M | 550.52M | 2.13B |
Operating Cash Flow | 0.00 | -413.22M | -517.62M | -683.38M | 565.65M | 2.14B |
Investing Cash Flow | 0.00 | -1.41B | -493.82M | -115.28M | -33.72M | -2.38M |
Financing Cash Flow | 0.00 | 96.66M | 0.00 | -3.07M | 3.79B | -6.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | 2.61T | 26.11 | 9.80% | 0.92% | 2.84% | 51.14% | |
70 Outperform | 72.77B | 11.02 | 10.02% | 3.31% | 20.73% | -17.60% | |
65 Neutral | 491.57B | 73.81 | 2.93% | 0.83% | 4.44% | -40.32% | |
58 Neutral | 15.14T | 51.50 | 10.23% | 0.89% | 2.30% | -24.75% | |
57 Neutral | 1.15T | 62.21 | 7.26% | 1.34% | -7.85% | -3.39% | |
50 Neutral | ¥12.48B | 82.71 | ― | ― | 23.91% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |
Coly Inc. reported its non-consolidated financial results for the fiscal year ending January 31, 2025, showing a significant increase in net sales by 28.4% to 6,500 million yen compared to the previous year. Despite this growth in sales, the company experienced operating and ordinary losses, with net income also in the negative, indicating ongoing financial challenges. The company’s financial position showed a decrease in total assets and net assets, and cash flow from operating activities remained negative, reflecting potential concerns for stakeholders regarding its financial health.